Health


 Futura Medical's Revenue Forecasts Upgraded Significantly

Futura Medical's Revenue Forecasts Upgraded Significantly

September 12, 2024 02:15 AM PDT| By Team Kalkine Media

Futura Medical PLC, operating in the,healthcare sector,, has reported a substantial upgrade in its revenue forecasts following its latest interim results, which surpassed expectations. The company's recent performance has positioned it to post its fi...

 Revolutionizing Wound Care: SOLV’s V.A.C. Peel and Place Dressing

Revolutionizing Wound Care: SOLV’s V.A.C. Peel and Place Dressing

September 11, 2024 06:24 PM PDT| By Team Kalkine Media

Innovative Solution for Wound Therapy,SOLV's latest launch, the V.A.C. Peel and Place Dressing, addresses longstanding challenges in negative pressure wound therapy. This cutting-edge product promises to make wound care more accessible and comfortabl...

 LivaNova Experiences Significant Increase in Three-Year Losses

LivaNova Experiences Significant Increase in Three-Year Losses

September 11, 2024 12:26 PM PDT| By Team Kalkine Media

LivaNova has reported a notable increase in its financial losses over the past three years, with losses growing to 44% compared to earlier periods. This trend highlights ongoing challenges faced by the company within the,healthcare sector,.,Financial...

 ANGLE Technology Sets the Standard in Cancer Diagnostics, Says Leading Financial Institution

ANGLE Technology Sets the Standard in Cancer Diagnostics, Says Leading Financial Institution

September 11, 2024 04:05 AM PDT| By Team Kalkine Media

ANGLE PLC,(OTC:ANPCF),is at the forefront of cancer diagnostics with its cutting-edge circulating tumour cell (CTC) technology. Recognized as the 'gold standard' in its field by a prominent German financial institution, the company’s Parsortix system...

 Berenberg Signals GSK's Challenges Are Clearing

Berenberg Signals GSK's Challenges Are Clearing

September 11, 2024 03:53 AM PDT| By Team Kalkine Media

GSK PLC,(OTC:GLAXF),has been noted by broker Berenberg, which highlights a potential easing of challenges that have impacted the pharmaceutical group throughout the summer. A major factor has been the Zantac litigation in Delaware, alongside concerns...

 Futura Medical Hits Profitability Early with Impressive Interim Results

Futura Medical Hits Profitability Early with Impressive Interim Results

September 11, 2024 03:37 AM PDT| By Team Kalkine Media

A major player of,Healthcare sector,, Futura Medical PLC has announced notable progress in its latest interim results, showcasing a significant milestone for the company. The results highlight the company’s successful transition to profitability earl...

 Liraglutide Shows Safety and Efficacy for Childhood Obesity in Recent Study

Liraglutide Shows Safety and Efficacy for Childhood Obesity in Recent Study

September 11, 2024 03:07 AM PDT| By Team Kalkine Media

The,healthcare sector,may see a significant development as new clinical findings indicate that liraglutide, a drug already approved for obesity treatment in adults and adolescents, is also safe and effective for children as young as six years old whe...

 GSK Halts Further Trials for Herpes Vaccine Following Disappointing Phase II Results

GSK Halts Further Trials for Herpes Vaccine Following Disappointing Phase II Results

September 11, 2024 02:55 AM PDT| By Team Kalkine Media

Shares of GSK PLC experienced a decline of over 1% after the,Healthcare secto,r company announced its decision to discontinue further trials for its experimental herpes vaccine, GSK3943104. The decision came in response to unsatisfactory results from...

 iRhythm's Zio Monitor Enhances Performance with Latest Study Findings

iRhythm's Zio Monitor Enhances Performance with Latest Study Findings

September 10, 2024 12:02 PM PDT| By Team Kalkine Media

Headlines,- iRhythm Technologies,(NASDAQ:IRTC),has unveiled promising results from the latest research on its Zio LTCM monitor, highlighting significant improvements in device performance.,- The Zio LTCM monitor, featuring a new design with a waterpr...

 Intrinsic Value Examination of 111 Inc. Reveals Current Market Insights

Intrinsic Value Examination of 111 Inc. Reveals Current Market Insights

September 10, 2024 09:43 AM PDT| By Team Kalkine Media

In the,Healthcare sector,, 111 Inc. has recently been evaluated to understand its intrinsic value and current market position. This sector, known for its dynamic nature and shifting consumer preferences, is vital in assessing how well companies like...

 Accuray’s Journey: Key Milestones on the Road to Breakeven

Accuray’s Journey: Key Milestones on the Road to Breakeven

September 10, 2024 09:42 AM PDT| By Team Kalkine Media

In the,healthcare sector,, Accuray Incorporated is a notable company engaged in the development and delivery of advanced radiation oncology systems. This sector, characterized by its focus on medical technology and innovation, is crucial for understa...

 Spectral AI Showcases Its Wound Care Device to Address Gaps in Burn Treatment

Spectral AI Showcases Its Wound Care Device to Address Gaps in Burn Treatment

September 10, 2024 09:20 AM PDT| By Team Kalkine Media

Spectral AI Inc.,(NASDAQ:MDAI),has underscored the role of its DeepView System in addressing disparities in burn care access, as highlighted by a recent report from the American Burn Association (ABA). The report, featured in the January/February 202...

 Futura Medical Reports Maiden Profit and Outlook

Futura Medical Reports Maiden Profit and Outlook

September 10, 2024 03:43 AM PDT| By Team Kalkine Media

Futura Medical PLC, a player in the,healthcare sector,, has announced a notable achievement with its first-ever profit. For the first half of 2024, the company reported a profit of £1 million on revenue of £7 million. The company concluded this perio...

 Qualigen Therapeutics (NASDAQ: QLGN) Raises $3.47 Million Through Public Offering, Plans Accelerated Debt Repayment and Expansion

Qualigen Therapeutics (NASDAQ: QLGN) Raises $3.47 Million Through Public Offering, Plans Accelerated Debt Repayment and Expansion

September 08, 2024 11:11 PM PDT| By Team Kalkine Media

Qualigen Therapeutics, Inc. (NASDAQ: QLGN) has successfully closed its public offering of 14,724,058 shares of common stock, priced at $0.13 per share. The offering also included pre-funded warrants to purchase up to 11,972,754 additional shares at a...

 VistaGen Therapeutics Gains Momentum with Rating Upgrade

VistaGen Therapeutics Gains Momentum with Rating Upgrade

September 06, 2024 06:34 PM PDT| By Team Kalkine Media

Headlines,- VistaGen Therapeutics,(NASDAQ:VTGN),has received a recent rating upgrade, reflecting positive shifts in its earnings outlook.,- Rising earnings estimates are linked to increased interest from institutional investors, which can impact shar...

 Ocuphire Pharma (Nasdaq:OCUP) Initiates VEGA-3 Phase 3 Trial for Presbyopia Treatment

Ocuphire Pharma (Nasdaq:OCUP) Initiates VEGA-3 Phase 3 Trial for Presbyopia Treatment

September 05, 2024 09:28 PM PDT| By Team Kalkine Media

Ocuphire Pharma, Inc. (Nasdaq:OCUP), a clinical-stage biopharmaceutical company specializing in ophthalmic treatments, has announced the commencement of its VEGA-3 Phase 3 clinical trial. The trial is evaluating Phentolamine Ophthalmic Solution 0.75%...

 Health Insurer Stocks Face Decline Amid Medicaid Enrollment Challenges

Health Insurer Stocks Face Decline Amid Medicaid Enrollment Challenges

September 04, 2024 01:09 PM PDT| By Team Kalkine Media

Headlines,- Health insurer stocks declined following concerns raised by Centene about Medicaid enrollments.,- Centene's CEO highlighted ongoing challenges with Medicaid eligibility redetermination.,- Medicaid enrollments have significantly decreased...

 Keytruda and Padcev Combo Secures EU Approval for Bladder Cancer Treatment

Keytruda and Padcev Combo Secures EU Approval for Bladder Cancer Treatment

September 04, 2024 12:19 PM PDT| By Team Kalkine Media

Headlines,The European Commission has approved the Keytruda and Padcev combination for treating advanced urothelial carcinoma.,The approval follows positive data from the phase III KEYNOTE-A39 study and earlier recommendations from European medical a...

 Vaxcyte Hits Record High with Promising Pneumococcal Vaccine Results

Vaxcyte Hits Record High with Promising Pneumococcal Vaccine Results

September 04, 2024 12:17 PM PDT| By Team Kalkine Media

Headlines,Breakthrough Study Results:,Vaxcyte's stock surged over 36% after announcing positive results from a Phase I/II trial of its 31-valent pneumococcal conjugate vaccine, VAX-31. The vaccine demonstrated strong immune responses across multiple...

 Ensign Expands with New Facilities in Kansas and Colorado

Ensign Expands with New Facilities in Kansas and Colorado

September 04, 2024 12:16 PM PDT| By Team Kalkine Media

Headlines,New Facility Acquisitions:,Ensign Group, Inc. has recently expanded its operations by adding a nursing facility in Overland Park, Kansas, and acquiring seven additional facilities across Colorado.,Growth in Footprint:,The new additions incl...

Recent Articles






Investing Tips

Previous Next